Canton Hathaway »

Biogen Idec shares owned by Canton Hathaway

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Canton Hathaway from 13F filings

Historical chart of Canton Hathaway investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Canton Hathaway consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Canton Hathaway

Quarter filed Position value Share count Share price at filing
2026-09-30 $6.8k 30 225.87
2019-12-31 $148k 500 296.00
2019-06-30 $4.0k 15 266.67
2019-03-31 $14k 60 233.33

More positions owned by Canton Hathaway

Berkshire Hathaway Inc A Cl A (BRK.A)
Vanguard 500 ETF Etf (VOO)
Bloom Energy Corp Class A Cl A (BE)
Microsoft Corporation (MSFT)
Ishares Msci Eafe Etf Etf (EFA)
Alphabet CL C (GOOG)
Spdr Gold Tr Gold Etf (GLD)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc B CL B (BRK.B)
Technology Select Sector SPDR ETF Etf (XLK)
Amazon (AMZN)
Select Sector Spdr Trust Shs Ben Int Energy Etf (XLE)
Industrial Select SPDR ETF Etf (XLI)
iShares Russell 2000 Etf (IWM)
iShares Silver Trust Etf (SLV)

View all positions for Canton Hathaway

Top funds holding Biogen Idec

FMR
BlackRock
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Wellington Management Company
Norges Bank Investment Management
AQR Capital Management
Jpmorgan Chase & Co
Invesco
Susquehanna International
UBS Group
Amundi

View all funds holding Biogen Idec